Accuracy and Performance Evaluation of Triplet Repeat Primed PCR as an Alternative to Conventional Diagnostic Methods for Fragile X Syndrome
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Conventional diagnosis of fragile X syndrome (FXS) is based on a combination of fragment analysis (FA) and Southern blotting (SB); however, this diagnostic approach is time- and labor-intensive and has pitfalls such as the possibility of missing large number alleles. Triplet repeat primed PCR (TP-PCR) is a current alternative used to overcome these limitations. We evaluated the diagnostic usefulness of TP-PCR compared with the conventional diagnostic protocol consisting of FA and/or SB in terms of allele categorization, repeat number correlation, and zygosity concordance in female genetic carriers. Methods: From November 2013 to March 2018, 458 patients (326 males, 132 females) were simultaneously examined using FA and/or SB and TP-PCR by detecting CGG repeat numbers in FMR1 gene and diagnosed as per American College of Medical Genetics guidelines. Results: The TP-PCR results showed high concordance with the FA and/or SB results for all three aspects (allele categorization, repeat number correlation, and zygosity concordance in female genetic carriers). TP-PCR detected CGG expansions ≥200 in all full mutation (FM) allele cases in male patients, as well as both the normal allele (NL) and FM allele in female carriers. In premutation (PM) allele carriers, the TP-PCR results were consistent with the FA and/or SB results. In terms of zygosity concordance in female genetic carriers, 12 NL cases detected by TP-PCR showed a merged peak consisting of two close heterozygous peaks; however, this issue was resolved using a 10-fold dilution. Conclusions: TP-PCR may serve as a reliable alternative method for FXS diagnosis.
Abstract
Background: Conventional diagnosis of fragile X syndrome (FXS) is based on a combination of fragment analysis (FA) and Southern blotting (SB); however, this diagnostic approach is time- and labor-intensive and has pitfalls such as the possibility of missing large number alleles. Triplet repeat primed PCR (TP-PCR) is a current alternative used to overcome these limitations. We evaluated the diagnostic usefulness of TP-PCR compared with the conventional diagnostic protocol consisting of FA and/or SB in terms of allele categorization, repeat number correlation, and zygosity concordance in female genetic carriers. Methods: From November 2013 to March 2018, 458 patients (326 males, 132 females) were simultaneously examined using FA and/or SB and TP-PCR by detecting CGG repeat numbers in FMR1 gene and diagnosed as per American College of Medical Genetics guidelines. Results: The TP-PCR results showed high concordance with the FA and/or SB results for all three aspects (allele categorization, repeat number correlation, and zygosity concordance in female genetic carriers). TP-PCR detected CGG expansions ≥200 in all full mutation (FM) allele cases in male patients, as well as both the normal allele (NL) and FM allele in female carriers. In premutation (PM) allele carriers, the TP-PCR results were consistent with the FA and/or SB results. In terms of zygosity concordance in female genetic carriers, 12 NL cases detected by TP-PCR showed a merged peak consisting of two close heterozygous peaks; however, this issue was resolved using a 10-fold dilution. Conclusions: TP-PCR may serve as a reliable alternative method for FXS diagnosis.
참고문헌 (18)
- Hagerman RJ, "Fragile X syndrome", Nat Rev Dis Primers, 3, pp.17065~ (2017)
- Tassone, F, "Advanced technologies for the molecular diagnosis of fragile X syndrome", Expert Rev Mol Diagn, 15, pp.1465~1473 (2015)
- Monaghan KG, "ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics", Genet Med, 15, pp.575~586 (2013)
- Biancalana V, "EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders", Eur J Hum Genet, 23, pp.417~425 (2015)
- "Practice guidelines for molecular diagnosis of fragile X syndrome"[URL]
- Lyon E, "A simple, high-throughput assay for Fragile X expanded alleles using triple repeat primed PCR and capillary electrophoresis", J Mol Diagn, 12, pp.505~511 (2010)
- Tassone F, "A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations", J Mol Diagn, 10, pp.43~49 (2008)
- Brykczynska U, "CGG repeat-induced FMR1 silencing depends on the expansion size in human iPSC’s and neurons carrying unmethylated full mutations", Stem Cell Reports, 7, pp.1059~1071 (2016)
- Jin Y, "Electrophoretic migration behavior of DNA fragments in polymer solution", Electrophoresis, 22, pp.2150~2158 (2001)
- Kiba Y, "Anomalously fast migration of triplet‐repeat DNA in capillary electrophoresis with linear polymer solution", Electrophoresis, 24, pp.452~457 (2003)
- Jin P, "Understanding the molecular basis of fragile X syndrome", Hum Mol Genet, 9, pp.901~908 (2000)
- Nolin SL, "Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles", Am J Med Genet A, 161A, pp.771~778 (2013)
- Sullivan AK, "Association of FMR1 repeat size with ovarian dysfunction", Hum Reprod, 20, pp.402~412 (2005)
- Wakeling EN, "Extra alleles in FMR1 triple-primed PCR: artifact, aneuploidy, or somatic mosaicism?", J Mol Diagn, 16, pp.689~696 (2014)
- Godler DE, "Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio", Hum Mol Genet, 19, pp.1618~1632 (2010)
- de Vries BB, "Mental status of females with an FMR1 gene full mutation", Am J Hum Genet, 58, pp.1025~1032 (1996)
- Loesch DZ, "Fragile X-associated tremor", ataxia phenotype in a male carrier of unmethylated full mutation in the FMR1 gene, 2012, pp.82, 88~92
- Wöhrle D, "Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats", J Med Genet, 35, pp.103~111 (1998)